semaglutide products Oral Dissolving Tablets - Needle-Free GLP-1 Weight Loss GLP-1 Semaglutide Rx | FancyMeds

Start today and invest in your future health.

Summary: Retatrutide may modestly reduce blood pressure as part of its broader cardiometabolic effects, but it remains an investigational medicine not yet licensed in the UK, and its full cardiovascular profile has not been established

Retatrutide is an investigational triple agonist activating GLP-1, GIP, and glucagon receptors simultaneously, with Phase 2 trials using once-weekly subcutaneous doses of 1 mg to 12 mg

2005 Nov 11;54(44):1127-30

By measuring changes in these marks, the team could assess whether the treatment was associated with a slower or faster biological aging pattern